Connect your AI

DocGo DCGO 2030

2030 at other companies

InfuSystem HoldingsINFU

——

Nutex Health Inc.NUTX

——

Medline, Inc. MDLN

——

Other financials

Income statement

Revenue$75.6M-21.3%

Gross profit-$407.9M-25.6%

Operating income-$18.7M-33.7%

Net income-$14.8M-57.0%

EPS (diluted)-$0.15-66.7%

Balance sheet

Cash & equivalents$46.8M-54.6%

Total debt$28.5M-7.6%

Total equity$132.3M-57.2%

Total assets$209.2M-51.4%

Cash flow

Operating cash flow-$4.7M-151%

CapEx$430.3K-58.2%

Free cash flow-$5.1M-162%

Valuation

Market cap$50.98M-67.2%

Enterprise value$32.67M-59.1%

P/S0.2×-0.2×

Profitability

Operating margin-60.6%—

Net margin-62.2%—

FCF margin14.6%+8.1pp

Returns & leverage

Return on equity-85%—

Debt / equity0.2×+0.1×

Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's 2030.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is DocGo's 2030?: DocGo (DCGO) reported 2030 of $132.87K in Q1 2026.
How has DocGo's 2030 changed year-over-year?: DocGo's 2030 decreased by 94.0% year-over-year, from $2.22M to $132.87K.